Scott Highlanders emerged victorious over the Oliver Spring Lady Bobcats with a score of 57-40 at Oliver Springs Gym. The game held the Tuesday night before Thanksgiving. The game showcased the ...

Before this season, Cody Lowe outlined how he wanted his Cosby girls basketball team to play. He wanted a fast-paced, transition-fueled game with plenty of pressing and turnovers forced on defense.

After contentious oral arguments, the justices are left with the task of determining whether Tennessee's law discriminates on the basis of sex or it regulates medical treatment within traditional ...

Tennessee can rest easy that it’ll make the College Football Playoff if it beats Vanderbilt, and it has a legitimate chance of hosting a first-round game at Neyland Stadium. Both possibilities ...

Effective Dec 1, 2024: The nature trail at Wes Skiles Peacock Springs State Park is currently closed due to ongoing hurricane cleanup efforts. Renamed to honor the late world-class explorer, diver, ...

stretching from Coffee County to the Tennessee River in Humphreys County. Many experts consider it to be the most diverse river in North America. At Henry Horton State Park, Ranger Samantha ...

A sculpture by the late Australian artist Bronwyn Oliver has fetched a record price for an Australian sculpture at auction. Ms Oliver died at the age of 47 in 2006, but her works continue to ...

Sarepta Therapeutics has turned to dealmaking to restock a drug pipeline analysts worried was growing thin, announcing Tuesday a deal with Arrowhead Pharmaceuticals that will give it four ...

Arrowhead Pharmaceuticals (NASDAQ:ARWR) added ~21% in the premarket on Tuesday after the company announced a global licensing and collaboration agreement with Sarepta Therapeutics (NASDAQ:SRPT ...

Sarepta Therapeutics is paying Arrowhead Pharmaceuticals $500 million in cash, plus a $325 million equity investment, for worldwide licensing rights to seven programs—four clinical and three ...

Sarepta Therapeutics said Tuesday that it will pay Arrowhead Pharmaceuticals $500 million in cash for a series of experimental RNA-based drugs to treat rare diseases in the muscle, nervous system ...